Associations of Ambient Air Pollutant Concentrations With Respiratory Symptoms and Perceived Health Status in Japanese Adults With and Without Chronic Respiratory Diseases: A Panel Study.


Journal

Journal of preventive medicine and public health = Yebang Uihakhoe chi
ISSN: 2233-4521
Titre abrégé: J Prev Med Public Health
Pays: Korea (South)
ID NLM: 101242972

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 02 07 2019
accepted: 06 11 2019
entrez: 5 12 2019
pubmed: 5 12 2019
medline: 23 5 2020
Statut: ppublish

Résumé

In recent years, transboundary air pollution from mainland East Asia has led to growing concerns about air pollution in Japan. Air pollution is reportedly associated with the exacerbation of respiratory diseases. In this study, we assessed the effects of air pollution on respiratory symptoms and the health status of participants with and without chronic respiratory diseases. Participants (n=2753) with and without chronic respiratory diseases who visited healthcare facilities in Japan during February from 2010 to 2015 filled out a self-report questionnaire regarding their symptoms and perceived health status. Participants were followed up during April-May and June-July. Oxidant concentrations were associated with respiratory symptoms, overall health, and quality of life (QoL). Suspended particulate matter (SPM) and particulate matter <2.5 μm levels were associated with physical fitness; SPM was also associated with QoL. Recent experience of an Asian sand dust event had a significant effect on allergic symptoms, change in health, and QoL. Respiratory symptoms were more strongly affected by oxidants than by other pollutants. Significant associations of air pollutants were found with a comprehensive range of items related to perceived health status, including overall health and QoL. Although the effects of air pollutants on respiratory symptoms and health status were more apparent among patients with respiratory diseases, the adverse effects of air pollutants were significant even among participants without such conditions.

Identifiants

pubmed: 31795618
pii: jpmph.19.180
doi: 10.3961/jpmph.19.180
pmc: PMC6893223
doi:

Substances chimiques

Air Pollutants 0
Dust 0
Particulate Matter 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

416-426

Subventions

Organisme : Ministry of Education, Culture, Sports, Science, and Technology

Références

Lancet. 2009 Aug 29;374(9691):733-43
pubmed: 19716966
Occup Environ Med. 2012 Dec;69(12):908-15
pubmed: 23085558
Environ Health Prev Med. 2014 Mar;19(2):172-6
pubmed: 24343755
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55
pubmed: 17507545
Thorax. 2014 Jul;69(7):660-5
pubmed: 24706041
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
Environ Sci Pollut Res Int. 2018 Mar;25(9):8074-8088
pubmed: 28547375
Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):743-8
pubmed: 25074374
Environ Sci Technol. 2012 May 1;46(9):4941-9
pubmed: 22435795
Int J Environ Health Res. 2005 Oct;15(5):383-91
pubmed: 16416755
Int J Environ Health Res. 2016 Aug;26(4):448-57
pubmed: 26788835
J Epidemiol Community Health. 2009 Oct;63(10):777-83
pubmed: 19468016
Stroke. 2012 Nov;43(11):3085-7
pubmed: 22968465
Epidemiology. 2005 Jul;16(4):436-45
pubmed: 15951661
Biometrics. 1986 Mar;42(1):121-30
pubmed: 3719049
Int J Environ Res Public Health. 2017 Feb 14;14(2):
pubmed: 28216601
Lancet. 2007 Sep 1;370(9589):765-73
pubmed: 17765526
Int J Environ Res Public Health. 2016 Dec 09;13(12):
pubmed: 27941665
Nihon Eiseigaku Zasshi. 2017;72(3):159-165
pubmed: 28931794
Environ Health Perspect. 2000 Aug;108 Suppl 4:713-23
pubmed: 10931790
Eur Respir J. 2001 May;17(5):1024-33
pubmed: 11488305
Am Rev Respir Dis. 1990 Nov;142(5):1158-63
pubmed: 2240838
J Epidemiol Community Health. 2006 Feb;60(2):173-9
pubmed: 16415270
Genes Environ. 2015 Dec 08;37:25
pubmed: 27350820
Sci Total Environ. 2012 May 1;424:182-92
pubmed: 22444053
Disabil Rehabil. 1993 Apr-Jun;15(2):96-101
pubmed: 8513163
Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):665-73
pubmed: 10673213
Respirology. 2016 Jan;21(1):14-23
pubmed: 26494423

Auteurs

Motoyuki Nakao (M)

Department of Public Health, School of Medicine, Kurume University, Kurume, Japan.

Keiko Yamauchi (K)

Department of Public Health, School of Medicine, Kurume University, Kurume, Japan.

Satoshi Mitsuma (S)

Niigata Association of Occupational Health Inc., Niigata, Japan.

Tetsuro Odaira (T)

Nishi-Niigata Chuo National Hospital, Niigata, Japan.

Hideto Obata (H)

Yamaguchi-ken Saiseikai Shimonoseki General Hospital, Yamaguchi, Japan.

Yoichi Chijimatsu (Y)

Chijimatsu Kokyuki Junkanki Naika Clinic, Yamaguchi, Japan.

Yoko Ishihara (Y)

Department of Public Health, School of Medicine, Kurume University, Kurume, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH